Healthcare provider profile · identity verified

Andrew Mcmillian Kellermann, DO

Internal Medicine · LELAND, NC · NPI 1871756122

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1146	304
Rosuvastatin Calcium	Rosuvastatin Calcium	755	210
Amlodipine Besylate	Amlodipine Besylate	639	179
Levothyroxine Sodium	Levothyroxine Sodium	523	148
Losartan Potassium	Losartan Potassium	411	119
Omeprazole	Omeprazole	405	130
Lisinopril	Lisinopril	359	105
Metoprolol Succinate	Metoprolol Succinate	328	93
Hydrochlorothiazide	Hydrochlorothiazide	296	90
Pantoprazole Sodium	Pantoprazole Sodium	274	86
Metformin Hcl	Metformin Hcl	269	78
Pravastatin Sodium	Pravastatin Sodium	261	71
Sertraline Hcl	Sertraline Hcl	214	64
Alprazolam	Alprazolam	190	67
Gabapentin	Gabapentin	175	49
Simvastatin	Simvastatin	157	49
Meloxicam	Meloxicam	151	57
Metformin Hcl Er	Metformin Hcl	149	48
Olmesartan Medoxomil	Olmesartan Medoxomil	145	41
Ozempic	Semaglutide	145	38
Allopurinol	Allopurinol	136	38
Tamsulosin Hcl	Tamsulosin Hcl	135	47
Escitalopram Oxalate	Escitalopram Oxalate	121	36
Ezetimibe	Ezetimibe	115	32
Carvedilol	Carvedilol	113	32
Clonazepam	Clonazepam	109	30
Fluticasone Propionate	Fluticasone Propionate	102	44
Zolpidem Tartrate	Zolpidem Tartrate	100	43
Tramadol Hcl	Tramadol Hcl	98	55
Clopidogrel	Clopidogrel Bisulfate	96	26
Bupropion Xl	Bupropion Hcl	95	35
Trazodone Hcl	Trazodone Hcl	94	27
Albuterol Sulfate Hfa	Albuterol Sulfate	91	41
Jardiance	Empagliflozin	89	21
Synthroid	Levothyroxine Sodium	87	22
Montelukast Sodium	Montelukast Sodium	83	22
Potassium Chloride	Potassium Chloride	83	30
Spironolactone	Spironolactone	83	18
Metoprolol Tartrate	Metoprolol Tartrate	82	25
Celecoxib	Celecoxib	81	24
Eliquis	Apixaban	77	20
Pioglitazone Hcl	Pioglitazone Hcl	76	24
Furosemide	Furosemide	70	24
Duloxetine Hcl	Duloxetine Hcl	64	25
Prednisone	Prednisone	64	49
Fluoxetine Hcl	Fluoxetine Hcl	61	17
Methocarbamol	Methocarbamol	61	36
Telmisartan	Telmisartan	58	16
Benazepril Hcl	Benazepril Hcl	55	16
Doxazosin Mesylate	Doxazosin Mesylate	55	18
Cephalexin	Cephalexin	54	41
Alendronate Sodium	Alendronate Sodium	53	15
Citalopram Hbr	Citalopram Hydrobromide	52	15
Diazepam	Diazepam	51	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	14
Mirtazapine	Mirtazapine	48	17
Sumatriptan Succinate	Sumatriptan Succinate	48	15
Trulicity	Dulaglutide	47	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	13
Paroxetine Hcl	Paroxetine Hcl	45	13
Pregabalin	Pregabalin	45	14
Ramipril	Ramipril	45	12
Atenolol	Atenolol	44	12
Farxiga	Dapagliflozin Propanediol	43	12
Lorazepam	Lorazepam	43	21
Ondansetron Odt	Ondansetron	41	21
Temazepam	Temazepam	41	suppressed
Oxycodone Hcl	Oxycodone Hcl	40	16
Buspirone Hcl	Buspirone Hcl	38	11
Glimepiride	Glimepiride	37	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	19
Lovastatin	Lovastatin	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	24
Valacyclovir	Valacyclovir Hcl	36	17
Valsartan	Valsartan	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	26
Methylprednisolone	Methylprednisolone	34	34
Amitriptyline Hcl	Amitriptyline Hcl	33	12
Finasteride	Finasteride	33	suppressed
Xarelto	Rivaroxaban	32	12
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Famotidine	Famotidine	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	16
Sucralfate	Sucralfate	28	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	suppressed
Indapamide	Indapamide	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	23
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Fluconazole	Fluconazole	23	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Dutasteride	Dutasteride	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	18
Colchicine	Colchicine	20	14
Irbesartan	Irbesartan	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Lactulose	Lactulose	20	suppressed
Linzess	Linaclotide	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Estradiol	Estradiol	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	15
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Testosterone	Testosterone	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	11
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Nystatin	Nystatin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Baclofen	Baclofen	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	12
Klor-Con M20	Potassium Chloride	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Atovaquone-Proguanil Hcl	Atovaquone/Proguanil Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	11
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error